tirzepatide support group Bk-Tirzepatide Bk-Tirzepatide

We report a rare case of acute SBO due to a bezoar in a 65-year-old woman who had been on semaglutide, a Glucagon-like peptide-1 (GLP-1) receptor agonist therapy for weight loss

Although total lean mass (baseline 51.3 kg) was also reduced by 2.3 kg and 1.5 kg with semaglutide and canagliflozin, respectively (estimated treatment difference: 0.78 [1.61, 0.04]), the proportion of lean mass (baseline 59.4%) increased by 1.2%- and 1.1%-point, respectively (estimated treatment difference 0.14 [0.89, 1.17])

Understanding your policy, exploring compounded alternatives, and considering genetic factors in peptide sensitivity may help guide treatment decisions with your provider

The varied types of angioedema have different triggers, including allergic reactions, genetic mutations, and immune system malfunction.

GLP-1

The available medical literature does not establish any association b...